Annual Operating Expenses
$21.04 M
+$4.19 M+24.89%
31 December 2023
Summary:
Cyclo Therapeutics annual total operating expenses is currently $21.04 million, with the most recent change of +$4.19 million (+24.89%) on 31 December 2023. During the last 3 years, it has risen by +$5.34 million (+34.04%). CYTH annual operating expenses is now at all-time high.CYTH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.51 M
+$2.76 M+48.06%
30 September 2024
Summary:
Cyclo Therapeutics quarterly total operating expenses is currently $8.51 million, with the most recent change of +$2.76 million (+48.06%) on 30 September 2024. Over the past year, it has increased by +$2.57 million (+43.24%). CYTH quarterly operating expenses is now at all-time high.CYTH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +43.2% |
| 3 y3 years | +34.0% | +158.7% |
| 5 y5 years | +152.8% | +215.2% |
CYTH Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.0% | at high | +173.3% |
| 5 y | 5 years | at high | +152.8% | at high | +416.5% |
| alltime | all time | at high | +8649.3% | at high | >+9999.0% |
Cyclo Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.51 M(+48.1%) |
| June 2024 | - | $5.75 M(+8.4%) |
| Mar 2024 | - | $5.30 M(-10.8%) |
| Dec 2023 | $21.04 M(+24.9%) | $5.94 M(+13.7%) |
| Sept 2023 | - | $5.22 M(+10.4%) |
| June 2023 | - | $4.73 M(-8.1%) |
| Mar 2023 | - | $5.15 M(+0.1%) |
| Dec 2022 | $16.85 M(+7.3%) | $5.14 M(+10.2%) |
| Sept 2022 | - | $4.67 M(+18.9%) |
| June 2022 | - | $3.92 M(+26.1%) |
| Mar 2022 | - | $3.11 M(-5.3%) |
| Dec 2021 | $15.70 M(+60.2%) | $3.29 M(-22.5%) |
| Sept 2021 | - | $4.24 M(+11.3%) |
| June 2021 | - | $3.81 M(-12.7%) |
| Mar 2021 | - | $4.36 M(+55.1%) |
| Dec 2020 | $9.80 M(+17.7%) | $2.81 M(+70.7%) |
| Sept 2020 | - | $1.65 M(-31.3%) |
| June 2020 | - | $2.40 M(-18.5%) |
| Mar 2020 | - | $2.94 M(+9.0%) |
| Dec 2019 | $8.32 M(+61.3%) | $2.70 M(+42.9%) |
| Sept 2019 | - | $1.89 M(+16.1%) |
| June 2019 | - | $1.63 M(-22.8%) |
| Mar 2019 | - | $2.11 M(+33.3%) |
| Dec 2018 | $5.16 M(+4.4%) | $1.58 M(+57.9%) |
| Sept 2018 | - | $1.00 M(-37.0%) |
| June 2018 | - | $1.59 M(+60.8%) |
| Mar 2018 | - | $988.80 K(-35.6%) |
| Dec 2017 | $4.95 M(+6.4%) | $1.53 M(+78.8%) |
| Sept 2017 | - | $858.40 K(-32.7%) |
| June 2017 | - | $1.27 M(-1.0%) |
| Mar 2017 | - | $1.29 M(+4.5%) |
| Dec 2016 | $4.65 M(+50.3%) | $1.23 M(+17.6%) |
| Sept 2016 | - | $1.05 M(-24.9%) |
| June 2016 | - | $1.40 M(+38.9%) |
| Mar 2016 | - | $1.00 M(-5.0%) |
| Dec 2015 | $3.09 M(+66.5%) | $1.06 M(+28.3%) |
| Sept 2015 | - | $824.60 K(+22.1%) |
| June 2015 | - | $675.30 K(+26.5%) |
| Mar 2015 | - | $534.00 K(-14.5%) |
| Dec 2014 | $1.86 M(+121.8%) | $624.50 K(+15.9%) |
| Sept 2014 | - | $538.80 K(+48.2%) |
| June 2014 | - | $363.60 K(+29.1%) |
| Mar 2014 | - | $281.70 K(+33.7%) |
| Dec 2013 | $837.20 K(+14.5%) | $210.70 K(-12.6%) |
| Sept 2013 | - | $241.20 K(+24.2%) |
| June 2013 | - | $194.20 K(+1.6%) |
| Mar 2013 | - | $191.20 K(+49.6%) |
| Dec 2012 | $730.90 K | $127.80 K(-21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $162.80 K(-11.7%) |
| June 2012 | - | $184.30 K(-28.0%) |
| Mar 2012 | - | $256.10 K(+10.9%) |
| Dec 2011 | $832.40 K(+19.0%) | $231.00 K(-4.0%) |
| Sept 2011 | - | $240.70 K(+60.9%) |
| June 2011 | - | $149.60 K(-29.1%) |
| Mar 2011 | - | $211.10 K(+27.9%) |
| Dec 2010 | $699.60 K(-2.0%) | $165.00 K(-7.0%) |
| Sept 2010 | - | $177.50 K(+57.2%) |
| June 2010 | - | $112.90 K(-53.8%) |
| Mar 2010 | - | $244.20 K(-15.5%) |
| Dec 2009 | $714.00 K(+31.5%) | $289.10 K(+97.7%) |
| Sept 2009 | - | $146.20 K(+21.8%) |
| June 2009 | - | $120.00 K(-24.4%) |
| Mar 2009 | - | $158.80 K(+14.0%) |
| Dec 2008 | $542.90 K(+23.6%) | $139.30 K(-5.4%) |
| Sept 2008 | - | $147.30 K(+27.0%) |
| June 2008 | - | $116.00 K(-13.8%) |
| Mar 2008 | - | $134.50 K(+55.9%) |
| Dec 2007 | $439.10 K(+25.2%) | $86.30 K(-26.2%) |
| Sept 2007 | - | $117.00 K(+37.8%) |
| June 2007 | - | $84.90 K(-43.7%) |
| Mar 2007 | - | $150.90 K(+377.5%) |
| Dec 2006 | $350.70 K(-29.9%) | $31.60 K(-73.2%) |
| Sept 2006 | - | $117.80 K(+14.8%) |
| June 2006 | - | $102.60 K(+4.0%) |
| Mar 2006 | - | $98.70 K(-12.6%) |
| Dec 2005 | $500.30 K(-24.7%) | $112.90 K(-36.4%) |
| Sept 2005 | - | $177.40 K(+69.6%) |
| June 2005 | - | $104.60 K(-0.8%) |
| Mar 2005 | - | $105.40 K(+326.7%) |
| Dec 2004 | $664.80 K(+131.9%) | $24.70 K(-74.7%) |
| Sept 2004 | - | $97.60 K(+2.2%) |
| June 2004 | - | $95.50 K(-29.6%) |
| Mar 2004 | - | $135.70 K(-6.5%) |
| Dec 2003 | $286.70 K(+19.2%) | $145.20 K(+219.1%) |
| Sept 2003 | - | $45.50 K(-2.8%) |
| June 2003 | - | $46.80 K(-4.9%) |
| Mar 2003 | - | $49.20 K(-31.9%) |
| Dec 2002 | $240.50 K(-13.8%) | $72.20 K(+49.8%) |
| Sept 2002 | - | $48.20 K(-15.1%) |
| June 2002 | - | $56.80 K(-10.4%) |
| Mar 2002 | - | $63.40 K(-3.2%) |
| Dec 2001 | $279.10 K(-26.8%) | $65.50 K(-12.6%) |
| Sept 2001 | - | $74.90 K(+17.0%) |
| June 2001 | - | $64.00 K(-14.3%) |
| Mar 2001 | - | $74.70 K(-47.3%) |
| Dec 2000 | $381.40 K | $141.80 K(+85.8%) |
| Sept 2000 | - | $76.30 K |
FAQ
- What is Cyclo Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly operating expenses year-on-year change?
What is Cyclo Therapeutics annual total operating expenses?
The current annual operating expenses of CYTH is $21.04 M
What is the all time high annual operating expenses for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual total operating expenses is $21.04 M
What is Cyclo Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CYTH is $8.51 M
What is the all time high quarterly operating expenses for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly total operating expenses is $8.51 M
What is Cyclo Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CYTH quarterly total operating expenses has changed by +$2.57 M (+43.24%)